IP Library Granted Patent US 12,502,264
Granted Patent B2
US 12,502,264 · App. 17/492,010 · Granted Dec 23, 2025

Injection apparatus and method for use

Inventors: Gershon Goldenberg (Pardes Hanna-Karkur, IL); Asaf Halamish (Pardes Hanna-Karkur, IL); Jonathan M. Bendheim (Jerusalem, IL); Avner Finger (Pardes Hanna-Karkur, IL); Udi Ashash (Sede Nahum, IL)
Assignee: phi-Tech Animal Health Technologies
A61D7/00A61M5/1408A61M5/1411A61M5/1413A61M5/14526A61M5/158A61M5/16813A61M2205/13A61M2250/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,502,264
App. No.
17/492,010
Granted
Dec 23, 2025
Kind
B2
Abstract

Disclosed devices for injection of medicament to a subject can include a hand-held unit, at least one control unit, and one or more medicament chambers fluidly coupled to the control unit. The hand-held unit having a head portion and a body portion, the head portion comprising at least one needle and a movable head, the movable head being axially movable relative to the body portion between an extended position and a retracted position. The control unit being fluidly coupled to the hand-held unit and having a pump having a dosing chamber.

Claims (14)

1 . An injection apparatus, comprising:

a hand-held unit having a body portion and a head portion removably coupled to the body portion, the body portion comprising a gripping portion extending at an angle relative to the head portion, the head portion comprising a support portion, at least one needle coupled to the support portion, a movable head movable axially relative to the support portion, and a safety cover removably coupled to the movable head, the safety cover being axially movable between a first configuration wherein a distal point of the needle is covered and a second position wherein the distal point of the needle is exposed, the safety cover comprising an angled opening extending from a distal end of the safety cover and a restraint portion, the angled opening configured to abut a subject and the restraint portion being configured to engage the subject to prevent movement of the subject relative to the safety cover; and

at least one control unit remote from the hand-held unit, configured to be worn by a user, and fluidly coupled to the hand-held unit via one or more connecting tubes, the at least one control unit comprising a pump having a piston.

2 . The injection apparatus of claim 1 , wherein the head portion comprises a threaded portion configured to engage a correspondingly threaded portion of the body portion.

3 . The injection apparatus of claim 1 , further comprising:

a protrusion extending from the head portion rearwardly toward the body portion;

a sensor coupled to the body portion, wherein when a selected length of the at least one needle is exposed from the movable head the protrusion engages the sensor, and when engaged, the sensor is configured to inject a medicament.

4 . The injection apparatus of claim 3 , wherein the medicament comprises Newcastle disease inactivated vaccine, IC Quadro, ND+IB+EDS, Ornitin Triple, Salmin Plus, Salmonella Infantis, poultry multivalent inactivated viral vaccines for Newcastle disease, infectious Bursal disease, infectious bronchitis, and reo viral arthritis, Natrium ceftiofur, Amikacin, Gentaject, and combinations thereof.

5 . The injection apparatus of claim 1 , wherein the movable head comprises a collection sleeve configured to collect medicament within the movable head, and wherein the needle comprises a groove configured to hold a selected dose of medicament.

6 . The injection apparatus of claim 1 , further comprising one or more medicament containers fluidly coupled to the at least one control unit.

7 . The injection apparatus of claim 1 , further comprising at least one control panel located on the at least one control unit and configured to allow an operator to input medicament dose volumes for one or more medicaments.

8 . The injection apparatus of claim 1 , wherein the pump is removably coupled to .

9 . The injection apparatus of claim 1 , wherein the pump comprises two or more non-return valves.

10 . The injection apparatus of claim 1 , wherein medicament is administered automatically upon insertion of the at least one needle to a selected depth within a subject.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2022
From: GOLDENBERG, GERSHON; HALAMISH, ASAF
To: PHI-TECH ANIMAL HEALTH TECHNOLOGIES LTD.
Reel/Frame 061139/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2022
From: BENDHEIM, JONATHAN M.; ASHASH, UDI; FINGER, AVNER
To: PHIBRO ANIMAL HEALTH CORPORATION
Reel/Frame 061139/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2022
From: PHIBRO ANIMAL HEALTH CORPORATION
To: PHI-TECH ANIMAL HEALTH TECHNOLOGIES LTD.
Reel/Frame 061141/0537 →
Continuity (5)
Continuation PCTIB2020053177 · Apr 30, 2020
Provisional Application 62954984 · Dec 30, 2019
Provisional Application 62872547 · Jul 10, 2019
Provisional Application 62829357 · Apr 4, 2019
Related Publication 20220023023A1 · Jan 27, 2022
References Cited (99)
US 4276879A · Yiournas · 1981 [cited by applicant]
US 4673395A · Philiips · 1987 [cited by applicant]
US 4717383A · Phillips et al. · 1988 [cited by applicant]
US 4985015A · Obermann · 1991 [cited by applicant]
US 5320162A · Seaman · 1994 [cited by applicant]
US 5807336A · Russo · 1998 [cited by applicant]
US 6858020B2 · Rusnak · 2005 [cited by applicant]
US 7056307B2 · Smith et al. · 2006 [cited by applicant]
US 8029469B2 · Ethelfield · 2011 [cited by applicant]
US 8529522B2 · Cohen · 2013 [cited by applicant]
US 9706754B2 · Prescott et al. · 2017 [cited by applicant]
US 10258445B2 · Halamish et al. · 2019 [cited by applicant]
US 20010008961A1 · Hecker · 2001 [cited by applicant]
US 20020183616A1 · Toews et al. · 2002 [cited by applicant]
US 20040134494A1 · Papania et al. · 2004 [cited by applicant]
US 20050043681A1 · Rusnak · 2005 [cited by examiner]
US 20050209569A1 · Ishikawa et al. · 2005 [cited by applicant]
US 20060135910A1 · Luther et al. · 2006 [cited by applicant]
US 20080114305A1 · Gerondale · 2008 [cited by applicant]
US 20080177223A1 · Johnston et al. · 2008 [cited by applicant]
US 20090018505A1 · Arguedas et al. · 2009 [cited by applicant]
US 20090163860A1 · Patrick · 2009 [cited by applicant]
US 20090198215A1 · Chong et al. · 2009 [cited by applicant]
US 20090270796A1 · Perry et al. · 2009 [cited by applicant]
US 20100130960A1 · Spire · 2010 [cited by applicant]
US 20120073515A1 · Chung et al. · 2012 [cited by applicant]
US 20120123386A1 · Tsals · 2012 [cited by examiner]
US 20140114258A1 · Day · 2014 [cited by applicant]
US 20150128873A1 · Prescott et al. · 2015 [cited by applicant]
US 20150174321A1 · Cohen · 2015 [cited by applicant]
US 20160101240A1 · Samson · 2016 [cited by applicant]
US 20160235512A1 · Miller et al. · 2016 [cited by applicant]
US 20160263321A1 · Eisele et al. · 2016 [cited by applicant]
US 20160296313A1 · Buckley et al. · 2016 [cited by applicant]
US 20160324613A1 · Halamish et al. · 2016 [cited by applicant]
US 20170197037A1 · Edwards · 2017 [cited by applicant]
US 20190183622A1 · Halamish et al. · 2019 [cited by applicant]
AU 727855 · 1999 [cited by applicant]
CA 2741441 · 2003 [cited by applicant]
CA 2959162 · 2016 [cited by applicant]
CN 1791440A · 2006 [cited by applicant]
CN 102105183A · 2011 [cited by applicant]
CN 203208448U · 2013 [cited by applicant]
CN 103458940A · 2013 [cited by applicant]
CN 104812334A · 2015 [cited by applicant]
CN 105597185A · 2016 [cited by applicant]
CN 105682607A · 2016 [cited by applicant]
CN 106029004A · 2016 [cited by applicant]
CN 106421978A · 2017 [cited by applicant]
CN 107468372 · 2017 [cited by applicant]
CN 106029004B · 2018 [cited by applicant]
EP 0747083A2 · 1996 [cited by applicant]
EP 2285436 · 2015 [cited by applicant]
EP 3089703A1 · 2016 [cited by applicant]
GB 2233234 · 1991 [cited by applicant]
WO WO2003082381A1 · 2003 [cited by applicant]
WO WO2004101060 · 2004 [cited by applicant]
WO WO2008057223 · 2008 [cited by applicant]
WO WO2008079824 · 2008 [cited by applicant]
WO WO2009062508A1 · 2009 [cited by applicant]
WO WO2009134577 · 2009 [cited by applicant]
WO WO2010052579 · 2010 [cited by applicant]
WO WO2012176029 · 2012 [cited by applicant]
WO WO2013064475 · 2013 [cited by applicant]
WO WO2014016807 · 2014 [cited by applicant]
WO WO2014107766 · 2014 [cited by applicant]
WO WO2015101981 · 2015 [cited by applicant]
WO WO2017086807 · 2017 [cited by applicant]
WO WO2017086924 · 2017 [cited by applicant]
WO WO2018092138 · 2018 [cited by applicant]
WO WO2018203203 · 2018 [cited by applicant]
WO WO2020002321A1 · 2020 [cited by applicant]
Office action for Chinese Application No. 201880029105.6, issued Dec. 28, 2021 (includes translation) (20 pages). [cited by applicant]
Office action for U.S. Appl. No. 16/667,405, issued Jan. 6, 2022 (19 pages). [cited by applicant]
Office action for Indian Application No. 201917048613, issued Feb. 17, 2022 (includes translation) (5 pages). [cited by applicant]
Office action for Chinese Application No. 201880079657.8, issued on Jul. 13, 2022 with Eng. Translation (24 pages). [cited by applicant]
Extended European Search Report, issued Dec. 2, 2022 in European Patent Application No. EPC 20784040.6, filed Apr. 3, 2020 (10 pages). [cited by applicant]
International Search Report and Written Opinion for PCT/IB2021/057450, dated Nov. 5, 2021 (14 pages). [cited by applicant]
Office action for Chinese Application No. 201880029105.6, issued Apr. 13, 2022 (with English translation) (25 pages). [cited by applicant]
Office Action for Russian Application No. 2020121737 issued on Apr. 26, 2022 (with English translation) (17 pgs). [cited by applicant]
Third Office Action for Chinese Application No. 201880029105.6 issued on May 18, 2022 (with English translation) (24 pgs). [cited by applicant]
Office action for Indian Application No. 202017024196 issued on Jun. 15, 2022 (with English translation) (7 pages). [cited by applicant]
Office Action for Israeli Application No. 246538, issued Dec. 12, 2019 (4 pages, translation incorporated into Office Action). [cited by applicant]
Office Action for Mexican Application No. MX/a/2016/008647, issued Jul. 19, 2019 (3 pages) (4 pages of translation). [cited by applicant]
Office Action for Mexican Application No. MX/a/2016/008647, issued Nov. 7, 2019 (4 pages) (5 pages of translation). [cited by applicant]
International Search Report & Written Opinion, PCT/IB2018/059883, mailed Mar. 25, 2019 (11 pages). [cited by applicant]
International Search Report & Written Opinion, PCT/IB2018/052958, mailed Aug. 12, 2018 (14 pages). [cited by applicant]
European Search Report, EP 14876301.4, dated Aug. 3, 2017 (3 pages). [cited by applicant]
Office action for European Application No. EPC 14876301.4 issued Mar. 10, 2020 (5 pages). [cited by applicant]
Office action for Brazil Application No. BR112016015342, issued May 13, 2020 (3 pages). [cited by applicant]
International Search Report & Written Opinion, PCT/IB2020/053177, dated Jul. 19, 2020 (20 pages). [cited by applicant]
Extended European Search Report, issued Sep. 1, 2020, European Patent Application No. EPC 18794760.1, filed Apr. 28, 2018 (10 pages). [cited by applicant]
Office Action for Israeli Application No. 246538, issued Jan. 21, 2021 (6 pages, Office Action and translation). [cited by applicant]
Office Action for Chinese Application No. 201880029105.6, issued Jun. 2, 2021 (24 pages, with English translation). [cited by applicant]
Office action for U.S. Appl. No. 16/285,865, issued Aug. 5, 2021 (7 pages). [cited by applicant]
Examination Report for European Application No. EP 18794760.1, issued by the European Patent Office on Aug. 6, 2021 (8 pages). [cited by applicant]
Examination Report for Russian Application No. 2019136958, issued by the Russian Patent Office on Aug. 18, 2021 (21 pages with Eng translation). [cited by applicant]
Examination Report for European Application No. EP 18888570.1, issued by the European Patent Office on Oct. 21, 2021 (13 pages). [cited by applicant]
Office action for Chinese Application No. 201880079657.8, issued Oct. 27, 2021 (7 pages). [cited by applicant]